Custodiol versus cold Calafiore for elective cardiac arrest in isolated aortic valve replacement: A propensity-matched analysis of 7263 patients

Abstract

OBJECTIVES: This study was designed to assess the impact of crystalloid cardioplegia (CCP) and blood cardioplegia (BCP) on short- and long-term outcome after isolated aortic valve replacement (AVR).METHODS: A total of 7263 patients undergoing AVR at our institution between November 1994 and June 2015 were identified. CCP (Custodiol®) was used in 83% (n = 5998) and intermittent cold BCP in 1007 patients (14%). For 4790 patients, propensity scores were calculated from baseline data, risk factors, comorbidities and characteristics of the disease, resulting in 825 pairs. The primary outcome was operative mortality (OM).RESULTS: There was no significant difference in OM between CCP and BCP cohorts [33 of 825 (4.0%) vs 35 of 825 (4.2%), P = 0.90]. The incidence of postoperative complications was comparable between both groups. Long-term survival was also not different between CCP and BCP (log-rank test: P = 0.9). Multiple Cox regression analysis demonstrated that mortality was significantly affected by renal function (P < 0.001), logistic EuroSCORE (P < 0.001), male sex (P = 0.005) and diabetes (P = 0.037). Patients with reduced left ventricular ejection fraction ≤ 30% showed improved survival when receiving BCP intraoperatively [odds ratio: 2.28 (1.12-4.63); P = 0.03].CONCLUSIONS: CCP and BCP provide equivalent outcome after isolated AVR. However, BCP seems to be beneficial for patients with reduced left ventricular ejection fraction.